CLS Holdings USA Inc (CLSH)
0.0578
+0.01
(+15.60%)
USD |
OTCM |
May 07, 12:22
CLS Holdings USA Gross Profit Margin (Quarterly): 43.17% for Feb. 29, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 43.17% |
| November 30, 2023 | 41.78% |
| August 31, 2023 | 44.46% |
| May 31, 2023 | 25.33% |
| February 28, 2023 | 47.19% |
| November 30, 2022 | 48.16% |
| August 31, 2022 | 47.98% |
| May 31, 2022 | 32.10% |
| February 28, 2022 | 51.66% |
| November 30, 2021 | 50.42% |
| August 31, 2021 | 52.65% |
| May 31, 2021 | 47.89% |
| Date | Value |
|---|---|
| February 28, 2021 | 45.23% |
| November 30, 2020 | 54.98% |
| August 31, 2020 | 52.69% |
| May 31, 2020 | 48.81% |
| February 29, 2020 | 52.30% |
| November 30, 2019 | 48.06% |
| August 31, 2019 | 50.63% |
| May 31, 2019 | 45.70% |
| February 28, 2019 | 39.38% |
| November 30, 2018 | 47.06% |
| August 31, 2018 | 35.56% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
25.33%
Minimum
May 2023
54.98%
Maximum
Nov 2020
46.56%
Average
48.02%
Median
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -88.65% |
| Profit Margin (Quarterly) | -88.69% |
| Operating Margin (Quarterly) | -8.90% |
| Return on Net Operating Assets | -101.3% |